Presenting on the above topic is Dato Dr Mohd Nazlee Kamal, CEO, Malaysian Biotechnology Corporationm Malaysia. He will be speaking at Pharma Partnering & Investment World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012.
With 25 years of diverse industry background in biotechnology including 10 years of executive management experience, Dr Nazlee brings in strong acumen in both the technical and business aspects of biotechnology to BiotechCorp. Recognised for his wide industrial leadership, Dr Nazlee played a pivotal role in the formulation of Malaysia's National Biotechnology Policy. He is a Board of Director of BiotechCorp, and the Chairman of Bio-XCell Sdn Bhd, a custom-built biotechnology park and ecosystem in Iskandar Malaysia for industrial and healthcare biotechnology.
Prior to BiotechCorp, Dr Nazlee was the CEO of Inno Biologics Sdn Bhd and the Group Managing Director of Inno Bio Ventures Sdn Bhd (2002-2011). Previous to Inno Bio Group of Companies, Nazlee has a wealth of experience encompassing marketing and technical portfolio with multinational companies such as Amersham Biosciences, Sartorius and BBraun. Dr Nazlee served ten years of tenure as a lecturer at the University of Technology Malaysia (1986-1996). He was responsible for the development of Bioprocess Engineering programme at the University. He invented the "External Spinfilter" now marketed by Sartorius BBI Systems (Patent No. PI9701436MY-131798-A). Dr Nazlee holds a PhD. in Chemical Engineering (Bioprocess) from University of Queensland, Brisbane, Australia.
Dr Nazlee will be speaking on the following topics:
1. Understanding the types of government funds available for catalyzing and financing new ventures and the eligibility criteria for these funds
2. Determining the impact government incentives and enabling polices have on the life science sector
3. Learning key incentives and government policies that enable biotech funding in Asia